What an incredible news this is.
Lots of women became victims of this “heartless” disease. The boosted development in recent years took it few spots up becoming the most common cancer in women.
Roughly said, it affects every 1 in 8 women. Even though 90% of these women will survive, the treatment can last for months.
The treatment for cancer is terrible not just for you. Everyone who cares about you and holds your hand while you are going through these tough times is sharing the same pain and concern.
The long process could be painful and exhausting. That’s why these new experiments make me cheer for science and medicine.
How it Works?
Several UK scientists found the treatment. They decided to show their incredible results at this year’s EBCC.
According to the research, the 11-days treatment relies on two drugs:
Both of these drugs directly attack the protein that boosts the cancer cells to grow. That’s HER2.
In their study, they tested these drugs by giving it to 257 women with HER2 fueled breast cancers.
The results came two weeks after. The Herceptin and Lapatinib managed to destroy cancer in 11% of the women completely.
In other 18%, the drugs have shrieked cancer significantly. The other patients, including Stage 2 breast cancer patients with the cancer spread to their lymph nodes, noticed improvements.
What if a Breast Cancer Patient Takes One or the Other Drug?
They didn’t give equal results. It wasn’t even near impressive as it was when the scientist tested both drugs together.
“This has groundbreaking potential. This offers the opportunity to tailor treatment for each woman.” – said Professor Nigel Bundred
If this experiment comes to life and doctors all around the world recognize its benefits, we can kiss goodbye the expensive chemotherapy and its dangerous side effects.
I hope the science will find more clues that this experiment works and make it even more efficient.
Keep in mind that both of these drugs are not side-effects free. Both can be the root for nausea, vomiting, fatigue, and rashes.
The Treatment Could Be Little bit “salty.”
By salty I mean expensive.
But don’t lose hope just yet. Maybe this new study will raise awareness, and it’s going to push cheaper variants of Lapatinib and Herceptin.
If there are more satisfied people from the treatment, I bet they’ll do anything to share it with the others.
There are communities of breast cancer patients that could see the benefit of this new treatment and spark the new prices.
Don’t forget to let your friends know about this.